Wolverine Asset Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Wolverine Asset Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,369	Closed	-$23K	–	2523
2022 Q3	$23K	Sell	2,369 -7,631	-76%	-$74.9K	﹤0.01%	1805
2022 Q2	$97K	Buy	10,000 +7,717	+338%	+$75.4K	﹤0.01%	1404
2022 Q1	$22K	Buy	+2,283	New	+$22.2K	﹤0.01%	1747
2021 Q4	–	Sell	-706	Closed	-$6K	–	2339
2021 Q3	$6K	Buy	+706	New	+$6.89K	﹤0.01%	1829

Other funds holding ORIA

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Wolverine Asset Management's ORIA Position: Q4 2022 in Review

Wolverine Asset Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q4 2022, closing a stake of 2,369 shares — an estimated $23K sold.

Wolverine Asset Management first reported a position in ORIA in Q3 2021 and held it in 4 quarters. The position peaked at $97K in Q2 2022. 51 funds tracked by Wall St. Rank hold ORIA as of Q4 2022.

Wolverine Asset Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q4 2022 after selling out during the quarter.
Wolverine Asset Management sold 2,369 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q4 2022, an estimated $23K.
Wolverine Asset Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 4 quarters.
Wolverine Asset Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $97K in Q2 2022.
51 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.